Pharmacological inhibition of polycomb repressive complex-2 activity induces apoptosis in human colon cancer stem cells.
about
Common stemness regulators of embryonic and cancer stem cellsThe roles of retinoic acid and retinoic acid receptors in inducing epigenetic changesEpigenetics in Intestinal Epithelial Cell RenewalPharmacological inhibition of EZH2 as a promising differentiation therapy in embryonal RMSCancer stem cell heterogeneity: origin and new perspectives on CSC targetingThe impact of microRNA-mediated PI3K/AKT signaling on epithelial-mesenchymal transition and cancer stemness in endometrial cancer.Prognostic value of polycomb proteins EZH2, BMI1 and SUZ12 and histone modification H3K27me3 in colorectal cancerHistone methylases as novel drug targets: developing inhibitors of EZH2.Wedelolactone disrupts the interaction of EZH2-EED complex and inhibits PRC2-dependent cancer.EZH2 inhibition enhances the efficacy of an EGFR inhibitor in suppressing colon cancer cellsDZNep inhibits the proliferation of colon cancer HCT116 cells by inducing senescence and apoptosis.Role of NADH Dehydrogenase (Ubiquinone) 1 Alpha Subcomplex 4-Like 2 in Clear Cell Renal Cell CarcinomaEnhancer of Zeste Homolog 2 Inhibition Attenuates Renal Fibrosis by Maintaining Smad7 and Phosphatase and Tensin Homolog ExpressionmiR-564 acts as a dual inhibitor of PI3K and MAPK signaling networks and inhibits proliferation and invasion in breast cancer.The polycomb group protein EZH2 is a novel therapeutic target in tongue cancer.Cancer Stem Cells: Dynamic Entities in an Ever-Evolving Paradigm.Down-regulation of miR-489 contributes into NSCLC cell invasion through targeting SUZ12.Targeting histone methylation for colorectal cancerSoft Tissue Sarcoma Cancer Stem Cells: An Overview
P2860
Q26777882-19ACFBA9-1BC2-4DCC-BFC7-FA1DCDBF78E1Q26866044-AF1385C3-CE46-4925-827C-04A2236C7877Q28071369-334052E4-55E3-4AD3-818B-258B64860BC8Q33592489-7525A6A1-ACAA-4574-BCB8-2F0593A8B6A2Q33649230-FE7BB3CA-A14F-434A-971F-7521220855B4Q34091442-41FFA0A9-F435-4169-BF01-38B448847807Q34226978-C100DDCB-DB7D-4489-8B55-33B5A2F9DBDEQ35510392-89FA6E70-D649-4C54-A5C0-9DAF5F0B60D6Q35955196-C8DC5135-05A7-4613-B60C-F9E6852685AFQ36212878-912A3BF1-38C1-4CA1-ABA9-785C9F3975DBQ36237945-20FC9ECB-C881-4739-894A-DEAD8111497DQ36963431-42DB514A-7FA4-4246-AABF-1CF4F151A863Q37052016-13968BB0-F51B-4371-AA19-38492F2E2DD7Q37236236-B81703BA-269B-4379-8778-5D3712D816CDQ37589165-7530F748-D9B4-4029-8F0B-4847B017F675Q38829440-F5799C51-2545-40BB-B34E-F1CA42242E93Q38891981-96A74758-6BA4-41D5-8DED-266D3A161847Q39175486-F396195D-E3DC-44D2-AD60-E85FE3AA6406Q58707604-E31EB701-4D93-4623-9B67-32C6C11BEB81
P2860
Pharmacological inhibition of polycomb repressive complex-2 activity induces apoptosis in human colon cancer stem cells.
description
article científic
@ca
article scientifique
@fr
articolo scientifico
@it
artigo científico
@pt
bilimsel makale
@tr
scientific article published on 12 April 2013
@en
vedecký článok
@sk
vetenskaplig artikel
@sv
videnskabelig artikel
@da
vědecký článek
@cs
name
Pharmacological inhibition of ...... human colon cancer stem cells.
@en
Pharmacological inhibition of ...... human colon cancer stem cells.
@nl
type
label
Pharmacological inhibition of ...... human colon cancer stem cells.
@en
Pharmacological inhibition of ...... human colon cancer stem cells.
@nl
prefLabel
Pharmacological inhibition of ...... human colon cancer stem cells.
@en
Pharmacological inhibition of ...... human colon cancer stem cells.
@nl
P2093
P2860
P1476
Pharmacological inhibition of ...... human colon cancer stem cells.
@en
P2093
Amel Guezguez
Jean-Francois Beaulieu
Kristian B Laursen
Lorraine J Gudas
Marco Beauséjour
Mavee S Witherspoon
Steven M Lipkin
Yannick D Benoit
P2860
P304
P356
10.1016/J.YEXCR.2013.04.006
P407
P577
2013-04-12T00:00:00Z